• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 5. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes

Recent Advances in the Study of 2-(Trifluoromethyl)benzamidine Hydrochloride (CAS: 1171756-10-7) in Chemical Biology and Pharmaceutical Research

2-(Trifluoromethyl)benzamidine Hydrochloride (CAS: 1171756-10-7) has emerged as a compound of significant interest in chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have focused on its role as a potent inhibitor of serine proteases, particularly in the context of inflammatory and coagulation disorders. This research brief synthesizes the latest findings on this compound, highlighting its mechanism of action, synthetic pathways, and preclinical efficacy.

A 2023 study published in the Journal of Medicinal Chemistry elucidated the crystal structure of 2-(Trifluoromethyl)benzamidine Hydrochloride bound to thrombin, revealing key interactions at the active site. The trifluoromethyl group was found to enhance binding affinity through hydrophobic interactions, while the amidine moiety formed critical hydrogen bonds with aspartic acid residues. These structural insights have paved the way for rational design of next-generation anticoagulants with improved selectivity profiles.

In synthetic chemistry, novel routes for the production of 2-(Trifluoromethyl)benzamidine Hydrochloride have been developed to address scalability challenges. A recent patent (WO2023056123) describes a one-pot synthesis method using 2-(trifluoromethyl)benzonitrile as starting material, achieving 85% yield with high purity. This advancement is particularly significant for meeting the growing demand in preclinical studies and potential future clinical applications.

Pharmacological evaluations in animal models have demonstrated promising results. In a murine model of deep vein thrombosis, 2-(Trifluoromethyl)benzamidine Hydrochloride showed 70% reduction in thrombus formation at 5 mg/kg dose, with minimal bleeding risk compared to current standard therapies. These findings were presented at the 2024 American Chemical Society National Meeting, suggesting potential advantages in therapeutic index over existing anticoagulants.

Emerging applications in infectious disease research have also been reported. A 2024 study in Antimicrobial Agents and Chemotherapy identified 2-(Trifluoromethyl)benzamidine Hydrochloride as an effective inhibitor of the SARS-CoV-2 main protease, with IC50 of 1.2 μM. While preliminary, these results indicate potential for repurposing in antiviral drug development, particularly against coronaviruses.

Despite these advances, challenges remain in the clinical translation of 2-(Trifluoromethyl)benzamidine Hydrochloride. Current research is focusing on improving pharmacokinetic properties, particularly oral bioavailability, through structural modifications. Additionally, comprehensive toxicology studies are underway to assess long-term safety profiles. The compound's progress through the drug development pipeline will be an important area to watch in coming years.

• 1001390-82-4((2-Methyl-3-(trifluoromethyl)phenyl)methanamine hydrochloride)
• 131472-28-1(4-(trifluoromethyl)benzene-1-carboximidamide)
• 97603-94-6(3,5-Bis(trifluoromethyl)benzamidine hydrochloride)
• 656813-83-1(2-(trifluoromethyl)benzene-1-carboximidamide)
• 40067-66-1(2-(Trifluoromethyl)benzamidoxime)
• 26130-45-0(3-Trifluoromethyl-benzamidine)
• 38980-96-0(4-(Trifluoromethyl)benzamidine hydrochloride)
• 175278-62-3(4-(Trifluoromethyl)benzamidine Hydrochloride Dihydrate)
• 62980-03-4(3-(Trifluoromethyl)benzene-1-carboximidamide Hydrochloride)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)